IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Copernicus Capital Management, LLC

Q3 2020 Holdings

Filed 2020-11-16 | 18 holdings | $28.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Abbvie Inc(ABBV)COM00287Y109$13.0M148,43945.5%
Biomarin Pharmaceutical Inc(BMRN)COM09061G101$12.6M165,18144.0%
Arcus Biosciences Inc(RCUS)COM03969F109$2.9M171,98210.3%
Bristol-Myers Squibb Co(BMY)COM110122108$12.9K213,3140.0%
Vertex Pharmaceuticals Inc(VRTX)COM92532F100$12.2K44,9890.0%
Arena Pharmaceuticals Inc(ARNAEUR)CALL040047607$6.4K85,5370.0%
Iqvia Hldgs Inc(IQV)COM46266C105$6.2K39,4320.0%
Fate Therapeutics Inc(FATE)COM31189P102$6.1K153,2970.0%
Myokardia IncCOM62857M105$5.8K42,1860.0%
GW Pharmaceuticals PLCADS36197T103$5.1K52,4880.0%
Teladoc Health Inc(TDOC)COM87918A105$4.7K21,5000.0%
Translate BIO IncCOM89374L104$3.1K227,7190.0%
Revolution Medicines Inc(RVMD)COM76155X100$2.8K81,0000.0%
Neurocrine Biosciences Inc(NBIX)COM64125C109$2.7K28,0000.0%
TG Therapeutics Inc(TGTX)COM88322Q108$2.5K95,0000.0%
Cymabay Therapeutics Inc(CBAYUSD)COM23257D103$2.0K278,4160.0%
Accolade Inc(ACCDEUR)COM00437E102$1.9K50,0000.0%
Eiger Biopharmaceuticals Inc(CLDNEUR)COM28249U105$1.9K238,1510.0%